Literature DB >> 29858440

Lesson of the month 2: An unusual adverse reaction associated with pramipexole.

Yasmina Tashkent1, Vinod Aiyappan2,3.   

Abstract

Dopamine agonists such as pramipexole are commonly used in the treatment of restless legs syndrome (RLS) as well as Parkinson's disease. Pramipexole's common side effects are well documented; however, adverse skin reactions are less well known. In this case, a 45-year-old male farmer presented with excessive daytime tiredness and reported a history suggestive of RLS. He was initiated on pramipexole but developed a maculopapular erythematous rash in sun-exposed areas 8 days after its commencement. The skin rash resolved following pramipexole's cessation and it is thought the patient experienced a drug-induced photosensitivity reaction to pramipexole. This case highlights the potential for photosensitivity reactions to pramipexole, which is especially significant in countries like Australia where UV solar radiation is especially high. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  Pramipexole; adverse reaction; skin

Mesh:

Substances:

Year:  2018        PMID: 29858440      PMCID: PMC6334071          DOI: 10.7861/clinmedicine.18-3-259

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  5 in total

Review 1.  Cutaneous photosensitivity diseases induced by exogenous agents.

Authors:  J W Gould; M G Mercurio; C A Elmets
Journal:  J Am Acad Dermatol       Date:  1995-10       Impact factor: 11.527

2.  Phototoxic Rash during Therapy with Pramipexole in a Patient with Restless Legs Syndrome.

Authors:  Husein H Elahmed
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

Review 3.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.

Authors:  M Dooley; A Markham
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

Review 5.  Dopamine agonists for restless legs syndrome.

Authors:  Hanna Scholz; Claudia Trenkwalder; Ralf Kohnen; Dieter Riemann; Levente Kriston; Magdolna Hornyak
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.